Within all the people who go to their doctor with obstructive sleep apnea (osa), 83% report having abnormal breathing sounds, 77% report having apnea, and 76% report having sleepiness. The symptoms that are highly suggestive of obstructive sleep apnea (osa) are abnormal breathing sounds, apnea, sleepiness, insomnia, and mouth dryness, although you may still have obstructive sleep apnea (osa) without those symptoms.
Patients with obstructive sleep apnea (osa) often receive other diagnostic procedures (interview; evaluation; consultation), other therapeutic procedures on eyelids; conjunctiva; cornea, ultrasonography, echocardiography, electroencephalogram (eeg), ophthalmologic and otologic diagnosis and treatment, referral to home health care service and other or upper gi therapeutic procedures .
The most commonly prescribed drugs for patients with obstructive sleep apnea (osa) include zaleplon (sonata), ropinirole, oxymetazoline nasal, pramipexole (mirapex), armodafinil (nuvigil), ciclesonide (omnaris), dihydroergotamine, valdecoxib (bextra), fluoxetine / olanzapine, drospirenone-estradiol, cascara sagrada, dipivefrin ophthalmic and calcium carbonate / famotidine / magnesium hydroxide .
Zaleplon (Sonata) | $35 (28 days) | |
Ropinirole | $41 (28 days) | |
Oxymetazoline Nasal | ||
Pramipexole (Mirapex) | $121 (28 days) | |
Armodafinil (Nuvigil) | $280 (28 days) | |
Ciclesonide (Omnaris) | $106 (28 days) | |
Dihydroergotamine | $517 (21 days) | |
Valdecoxib (Bextra) | ||
Drospirenone-Estradiol | ||
Cascara Sagrada | ||
Dipivefrin Ophthalmic |
Groups of people at highest risk for obstructive sleep apnea (osa) include age 60-74 years age 45-59 years. On the other hand, age < 1 years almost never get obstructive sleep apnea (osa).
< 1 years | 0.0x | |
1-4 years | 0.3x | |
5-14 years | 0.5x | |
15-29 years | 0.3x | |
30-44 years | 1.1x | |
45-59 years | 1.8x | |
60-74 years | 1.7x | |
75+ years | 0.6x |
Male | 1.3x | |
Female | 0.8x |
Black | 0.8x | |
Hispanic | 0.6x | |
White | 1.2x | |
Other | 0.8x |